BI
bioAffinity Technologies, Inc.
BIAFW · NASDAQ
$0.45 -27.42% (-$0.17)
1M +685.71%
Market Cap $2.04M
P/E Ratio -
Div. Yield -
ROE 257.27%
Piotroski F-Score Weak
3/9Valuation
100 /100
Cheap P/S 0.35x
P/B 0.54x
P/E N/A
Growth
-
N/A EPS growth N/A
Rev. growth N/A
FCF growth N/A
Profitability
0 /100
Weak Gross margin 39.57%
Net margin 257.33%
Op. margin 209.82%
Quality
10 /100
Poor ROIC 238.03%
ROE 257.27%
ROA 199.30%
Debt
59 /100
Moderate Debt/Equity 0.38x
Current ratio 1.44x
Int. coverage -337.54x
Stability
22 /100
Unstable Beta -1.05x
EPS volatility 74.26%
Profitable years 0
Bulios Scoring opisuje jakość i historię firmy, a nie przyszły zwrot. Wysoki wynik to nie sygnał zakupu. Dowiedz się więcej
Zapytaj StockBota o BIAFW
Online
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Maria Zannes
Employees
57
Headquarters
San Antonio
Nadchodzące wydarzenia
18 LIS
Earnings
Upcoming earnings report